The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
Open accessAbstract
Interleukin 23 (IL-23) and IL-17 have been linked to the pathogenesis of several chronic inflammatory disorders, including inflammatory bowel disease. Yet as an important function for IL-23 is emerging, the function of IL-17 in inflammatory bowel disease remains unclear. Here we demonstrate IL-17A-mediated protection in the CD45RBhi transfer model of colitis. An accelerated wasting disease elicited by T cells deficient in IL-17A correlated with higher expression of genes encoding T helper type 1-type cytokines in colon tissue. IL-17A also modulated T helper type 1 polarization in vitro. Furthermore, T cells deficient in the IL-17 receptor elicited an accelerated, aggressive wasting disease relative to that elicited by wild-type T cells in recipient mice. Our data demonstrate a protective function for IL-17 and identify T cells as not only the source but also a target of IL-17 in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given that IL-17A- and IL-22-producing Th17 cells appear to be protective rather than pathogenic in the intestines (84)”
From T H 17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity (2020) · cites this paper as [84]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K. P., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,819
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,371
Self-citationInterleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P. A., Kasman, I. M., Eastham‐Anderson, J., Wu, J., & Ouyang, W. (2006) · Nature · doi:10.1038/nature05505 · Cited by 1,888
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,848
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Cited by
Sorted by citations
Items 301–400 of 756
Däbritz, J. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00409.2013 · Cited by 56
IL-17A–Dependent CD4+CD25+ Regulatory T Cells Promote Immune Privilege of Corneal Allografts
Cunnusamy, K., Chen, P. W., & Niederkorn, J. Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100101 · Cited by 56
IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation
Awasthi, A., & Kuchroo, V. K. (2009) · Nature Immunology · doi:10.1038/ni0609-568 · Cited by 55
Protective Role of Interleukin-17 in Murine NKT Cell-Driven Acute Experimental Hepatitis
Wondimu, Z., Santodomingo-Garzón, T., Le, T. P., & Swain, M. G. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100028 · Cited by 56
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
Scheau, C., Căruntu, C., Bădărău, I. A., Scheau, A.-E., Docea, A. O., Călina, D. C., & Căruntu, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060494 · Cited by 54
Löfgren's Syndrome: Diagnosis, Management, and Disease Pathogenesis
Kaiser, Y., van Moorsel, C. H. M., Grünewald, J., & Karakaya, B. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1602380 · Cited by 77
Zhang, Y., Zhao, X., Zhu, Y., Ma, J., Ma, H., & Zhang, H. (2018) · Mediators of Inflammation · doi:10.1155/2018/9416391 · Cited by 53
IL-23 inhibition for chronic inflammatory disease
Jairath, V., Felquer, M. L. A., & Cho, R. J. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01750-1 · Cited by 54
Chiu, C.-C., Ching, Y., Wang, Y., Liu, J.-Y., Li, Y.-P., Huang, Y.-T., & Chuang, H.-L. (2014) · BioMed Research International · doi:10.1155/2014/675786 · Cited by 53
Therapeutic Targets in Inflammatory Bowel Disease: Current and Future
Bilsborough, J., Targan, S. R., & Snapper, S. B. (2016) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2016.18 · Cited by 51
Hayashi, R., Tahara, T., Shiroeda, H., Saito, T., Nakamura, M., Tsutsumi, M., Shibata, T., & Arisawa, T. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0206-5 · Cited by 51
Odobasic, D., Gan, P., Summers, S. A., Semple, T. J., Muljadi, R. C. M., Iwakura, Y., Kitching, A. R., & Holdsworth, S. R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.039 · Cited by 51
Self-citationFitzpatrick, L. R. (2012) · International Journal of Inflammation · doi:10.1155/2012/389404 · Cited by 51
Califano, D., Sweeney, K. J., Le, H., VanValkenburgh, J., Yager, E. J., O’Connor, W., Kennedy, J. S., Jones, D. M., & Avram, D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70103 · Cited by 51
Immunomodulatory Properties of Induced Pluripotent Stem Cell‐Derived Mesenchymal Cells
Ng, J. Q., Hynes, K., White, G., Sivanathan, K. N., Vandyke, K., Bartold, P. M., & Gronthos, S. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25596 · Cited by 51
Sun, X., Yamada, H., Shibata, K., Muta, H., Tani, K., Podack, E. R., Iwakura, Y., & Yoshikai, Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002229 · Cited by 51
Self-citationBendix, M., Bartels, L. E., Agnholt, J. S., Dige, A. K., Jørgensen, S. P., & Dahlerup, J. F. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04463.x · Cited by 52
de Mendizábal, N. V., Carneiro, J., Solé, R. V., Goñi, J., Bragard, J. R., Martínez‐Forero, I., Martinez‐Pasamar, S., Sepulcre, J., Torrealdea, J., Bagnato, F. R., et al. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-114 · Cited by 51
Myeloid-derived Suppressor Cells in the Inflammatory Bowel Diseases
Ostanin, D. V., & Bhattacharya, D. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182902b11 · Cited by 49
Schmitz, S. S., Garden, O. A., Werling, D., & Allenspach, K. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.01.013 · Cited by 50
Cell death programs in Yersinia immunity and pathogenesis
Philip, N. H., & Brodsky, I. E. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00149 · Cited by 45
Ray, S., Salvo, C. D., & Pizarro, T. T. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000119 · Cited by 50
Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease
Ishikawa, D., Okazawa, A., Corridoni, D., Li, J., Wang, X. M., Guanzon, M., Xin, W., Arseneau, K. O., Pizarro, T. T., & Cominelli, F. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.67 · Cited by 50
IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice
Visperas, A., Do, J., Bulek, K., Li, X., & Min, B. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.82 · Cited by 49
Ramani, K., Pawaria, S., Maers, K., Huppler, A. R., Gaffen, S. L., & Biswas, P. S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0414-184r · Cited by 48
Jabeen, M., & Hinks, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127588 · Cited by 49
Microbiota-specific Th17 Cells
Wu, W. H., Chen, F., Liu, Z., & Cong, Y. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000775 · Cited by 50
Wang, X., Ni, L., Chang, D., Li, J., Jiang, Y., Kim, B., Wang, A., Liu, X., Zhong, B., Yang, X. O., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.010 · Cited by 46
Burstein, V. L., Guasconi, L., Beccacece, I., Theumer, M. G., Mena, C. J., Prinz, I., Cervi, L., Herrero, M., Masih, D. T., & Chiapello, L. S. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.02.042 · Cited by 49
Pastorelli, L., Salvo, C. D., Cominelli, M. A., Vecchi, M. L., & Pizarro, T. T. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11410770 · Cited by 48
Xu, Z., Cheng, W., ZHANG, R., Yao, J., ZHANG, D., & Wang, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2824 · Cited by 47
Bassolas-Molina, H., Raymond, E. L., Labadia, M. E., Wahle, J. A., Ferrer-Picón, E., Panzenbeck, M., Zheng, J., Harcken, C., Hughes, R. O., Turner, M. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02307 · Cited by 47
Smith, M. K., Pai, J., Panaccione, R., Beck, P. L., Ferraz, J. G., & Jijon, H. B. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1067-0 · Cited by 47
The Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells
Lochner, M., Wang, Z., & Sparwasser, T. D. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.013 · Cited by 48
Vanbervliet, B., Akdiş, M., Vocanson, M., Rozières, A., Bénetière, J., Rouzaire, P., Akdiş, C. A., Nicolas, J., & Hennino, A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.002 · Cited by 46
Mattarollo, S. R., Steegh, K., Li, M., Duret, H., Ngiow, S. F., & Smyth, M. J. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.58 · Cited by 46
Li, M., Gao, J., Tang, Y., Liu, M., Wu, S., Qu, K., Long, X., Li, H., Liu, M., Liu, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00959 · Cited by 46
Interleukin 23 in Crohnʼs Disease
Eken, A., Singh, A. K., & Oukka, M. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000442014.52661.20 · Cited by 46
IL-17 Promotes Immune Privilege of Corneal Allografts
Cunnusamy, K., Chen, P. W., & Niederkorn, J. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001576 · Cited by 45
TH Cells and Cytokines in Encephalitogenic Disorders
Krishnarajah, S., & Becher, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.822919 · Cited by 49
Interaction between microbiota and immunity and its implication in colorectal cancer
Xing, C., Du, Y., Duan, T., Nim, K., Chu, J., Wang, H. Y., & Wang, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963819 · Cited by 47
Yadav, M., Huang, M., & Goetzl, E. J. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.01.001 · Cited by 44
Wang, R., Hasnain, S. Z., Tong, H., Das, I., Chen, A. C. –., Oancea, I., Proctor, M. A., Florin, T. H., Eri, R. D., & McGuckin, M. A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000353 · Cited by 44
Natural Killer T Cells within the Liver: Conductors of the Hepatic Immune Orchestra
Swain, M. G. (2010) · Digestive Diseases · doi:10.1159/000282059 · Cited by 43
Two Different Regulatory T Cell Populations That Promote Corneal Allograft Survival
Cunnusamy, K., Paunicka, K., Reyes, N. S., Yang, W., Chen, P. W., & Niederkorn, J. Y. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6161 · Cited by 44
Erdmann, H., Roßnagel, C., Böhme, J., Iwakura, Y., Jacobs, T., Schaible, U. E., & Hölscher, C. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.10.005 · Cited by 44
Self-citationTang, W.-H., Wang, H.-S., Claudio, E., Tassi, I., Ha, H., Saret, S., & Siebenlist, U. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.017 · Cited by 43
TLR5 mediates CD172α+ intestinal lamina propria dendritic cell induction of Th17 cells
Liu, H., Chen, F., Wu, W. H., Cao, A., Xue, X., Yao, S., Evans‐Marin, H., Li, Y., & Cong, Y. (2016) · Scientific Reports · doi:10.1038/srep22040 · Cited by 47
The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment
Ducimetière, L., Vermeer, M., & Tugues, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02895 · Cited by 49
SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation
Uza, N., Nakase, H., Yamamoto, S., Yoshino, T., Takeda, Y., Ueno, S., Inoue, S., Mikami, S., Matsuura, M., Shimaoka, T., et al. (2011) · Gut · doi:10.1136/gut.2010.221879 · Cited by 42
Sato, K., Miyoshi, F., Yokota, K., Araki, Y., Asanuma, Y., Akiyama, Y., Yoh, K., Takahashi, S., Aburatani, H., & Mimura, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.218867 · Cited by 44
Saraiva, A. M., Silva, M. R. M. A. E., Silva, J. D. F. C., Costa, J. E., Gollob, K. J., Dutra, W. O., & Moreira, P. R. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.10.026 · Cited by 42
Jie, Z., Liang, Y., Hou, L., Dong, C., Iwakura, Y., Soong, L., Cong, Y., & Sun, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303281 · Cited by 43
Self-citationProtective role of γδ T cells in cigarette smoke and influenza infection
Hong, M. J., Gu, B., Madison, M. C., Landers, C. T., Tung, H. Y., Kim, M.-J., Yuan, X., You, R., Machado, A. A., Gilbert, B. E., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.93 · Cited by 42
Cellular Mediators of Inflammation: Tregs and TH17 Cells in Gastrointestinal Diseases
Pandolfi, F., Cianci, R., Pagliari, D., Landolfi, R., & Cammarota, G. (2009) · Mediators of Inflammation · doi:10.1155/2009/132028 · Cited by 45
IL-17A and IL-17F Expression in B Lymphocytes
Vazquez‐Tello, A., Halwani, R., Li, R., Nadigel, J., Bar-Or, A., Mazer, B. D., Eidelman, D. H., Al‐Muhsen, S., & Hamid, Q. A. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000329527 · Cited by 41
Th17 Cytokines in Inflammatory Bowel Diseases: Discerning the Good from the Bad
Troncone, E., Marafini, I., Pallone, F., & Monteleone, G. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.823421 · Cited by 41
Pig models on intestinal development and therapeutics
Yin, L., Yang, H., Li, J., Li, Y., Ding, X., Wu, G., & Yin, Y. (2017) · Amino Acids · doi:10.1007/s00726-017-2497-z · Cited by 41
IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Trypanosoma cruzi Infection
Tosello, J., Furlan, C. L. A., Vernengo, F. F., Rodríguez, C., Ramello, M. C., Vesely, M. C. A., Serrán, M. G., Núñez, N. G., Richer, W., Piaggio, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02347 · Cited by 40
The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts
Kato, H., Endres, J., & Fox, D. A. (2013) · Modern Rheumatology · doi:10.1007/s10165-012-0811-x · Cited by 41
Immunopathogenesis and distinct role of Th17 in periodontitis: A review
Kini, V. V., Mohanty, I. R., Telang, G., & Vyas, N. (2022) · Journal of Oral Biosciences · doi:10.1016/j.job.2022.04.005 · Cited by 40
Bi, Y., Zhou, J., Yang, H., Zhang, X., Zhang, X., Wang, Q., Wu, X., Yanping, H., Song, Y., Tan, Y., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301687 · Cited by 40
Impact of Interleukin-17 on Macrophage Phagocytosis of Apoptotic Neutrophils and Particles
Silverpil, E., Glader, P., Hansson, M., & Lindén, A. (2010) · Inflammation · doi:10.1007/s10753-010-9201-8 · Cited by 41
Nakagawa, R., Yoshida, H., Asakawa, M., Tamiya, T., Inoue, N., Morita, R., Inoue, H., Nakao, A., & Yoshimura, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100649 · Cited by 40
Computational modeling of heterogeneity and function of CD4+ T cells
Carbo, A., Hontecillas, R., Andrew, T., Eden, K. B., Mei, Y., Hoops, S., & Bassaganya-Riera, J. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00031 · Cited by 43
Do, J., Kim, S., Keslar, K. S., Jang, E., Huang, E. H., Fairchild, R. L., Pizarro, T. T., & Min, B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601060 · Cited by 39
Can IL-23 be a good target for ulcerative colitis?
Allocca, M., Furfaro, F., Fiorino, G., Gilardi, D., D’Alessio, S., & Danese, S. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.05.016 · Cited by 40
Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis
Campanati, A., Paolinelli, M., Diotallevi, F., Martina, E., Molinelli, E., & Offidani, A. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1681969 · Cited by 41
Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis
Latella, G., & Viscido, A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06161-1 · Cited by 41
Not all monoclonals are created equal – Lessons from failed drug trials in Crohn's disease
Kaser, A. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.04.005 · Cited by 40
Recipe for IBD: can we use food to control inflammatory bowel disease?
Witkowski, M., Witkowski, M., Gagliani, N., & Huber, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0658-5 · Cited by 39
Bourgonje, A. R., von Martels, J. Z. H., de Vos, P., Faber, K. N., & Dijkstra, G. D. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193202 · Cited by 39
Type 3 cytokines in liver fibrosis and liver cancer
Molina, M. F., Abdelnabi, M. N., Fabre, T., & Shoukry, N. H. (2018) · Cytokine · doi:10.1016/j.cyto.2018.07.028 · Cited by 41
Intestinal Epithelial Responses to IL-17 in Adult Stem Cell-derived Human Intestinal Organoids
Lee, C., Song, J. H., Cha, Y.-E., Chang, D. K., Kim, Y., & Hong, S. N. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac101 · Cited by 39
Emerging therapies for ulcerative colitis
Hanžel, J., Hulshoff, M. S., Grootjans, J., & D’Haens, G. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2069562 · Cited by 40
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Bedoya, S. K., Wilson, T. D., Collins, E. L., Lau, K., & Larkin, J. (2013) · Journal of Visualized Experiments · doi:10.3791/50765 · Cited by 37
Silverpil, E., & Lindén, A. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.12 · Cited by 38
Immunopathogenesis of inflammatory bowel diseases: functional role of T cells and T cell homing.
Zundler, S., & Neurath, M. F. (2015) · PubMed · Cited by 38
Development of experimental cerebral malaria is independent of IL-23 and IL-17
Ishida, H., Matsuzaki‐Moriya, C., Imai, T., Yanagisawa, K., Nojima, Y., Suzue, K., Hirai, M., Iwakura, Y., Yoshimura, A., Hamano, S., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.114 · Cited by 37
Self-citationThe immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis
Kim, S. D., Kwon, S., Lee, S. K., Kook, M., Lee, H. Y., Song, K., Lee, H., Baek, S., Park, C. B., & Bae, Y. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.77 · Cited by 38
Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases
Akiyama, S., & Sakuraba, A. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100104 · Cited by 43
Wang, M., Zhang, L., Chang, W., & Zhang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1096551 · Cited by 44
Zakostelska, Z. J., Reiss, Z., Tlaskalová‐Hogenová, H., & Rob, F. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-00904-4 · Cited by 41
Dimitriou, F., Cheng, P. F., Saltari, A., Schaper‐Gerhardt, K., Staeger, R., Haunerdinger, V., Sella, F., Tastanova, A., Urban, C., Dettwiler, S., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00810-4 · Cited by 41
Brown, J. B., Cheresh, P., Zhang, Z., Ryu, H., Managlia, E. Z., & Barrett, T. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21779 · Cited by 37
Brasseit, J., Chung, C. K. C. K., Noti, M., Zysset, D., Dickgreber, N., Genitsch, V., Corazza, N., & Mueller, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00023 · Cited by 37
Exploring the role of gut microbiome in autoimmune diseases: A comprehensive review
Wang, H., Cai, Y., Wu, W. ‐., Zhang, M., Dai, Y., & Wang, Q. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103654 · Cited by 42
Ahlers, J. D., & Belyakov, I. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.007 · Cited by 37
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease
Verstockt, B., Assche, G. V., Vermeire, S., & Ferrante, M. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1258399 · Cited by 36
IL-17A–Mediated Protection against Acanthamoeba Keratitis
Suryawanshi, A. S., Cao, Z., Sampson, J. F., & Panjwani, N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302707 · Cited by 37
Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization
McAleer, J. P., Liu, B., Li, Z., Ngoi, S., Dai, J., Oft, M., & Vella, A. T. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909631 · Cited by 36
Cho, H., Shin, H. M., Haberstock-Debic, H., Xing, Y., Owens, T. D., Funk, J. O., Hill, R. J., Bradshaw, J. M., & Berg, L. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501828 · Cited by 36
Review: T helper 17 cells: Their role in glomerulonephritis
Ooi, J. D., Kitching, A. R., & Holdsworth, S. R. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01343.x · Cited by 37
Okuyama, H., Tominaga, A., Fukuoka, S., Taguchi, T., Kusumoto, Y., & Ono, S. (2017) · Oncology Reports · doi:10.3892/or.2017.5346 · Cited by 37
Arachchi, P. S., Fernando, N., Weerasekera, M. M., Senevirathna, B., Weerasekera, D. D., & Gunasekara, C. P. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/6265150 · Cited by 35
Sun, M., He, C., Chen, L., Yang, W., Wu, W. H., Chen, F., Cao, A., Yao, S., Dann, S. M., Dhar, T. G. M., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701697 · Cited by 35
IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon
Walrath, T., Malizia, R. A., Zhu, X. C., Sharp, S. P., D’Souza, S. S., Lopez‐Soler, R. I., Parr, B. A., Kartchner, B. J., Lee, E. C., Stain, S. C., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00208.2019 · Cited by 35
Self-citationRole of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice
Li, J., Liu, L., Zhao, Q., & Chen, M. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05969-w · Cited by 35
Brodalumab: A new way to inhibit IL ‐17 in psoriasis
Facheris, P., Valenti, M., Pavia, G., Guanziroli, E., Narcisi, A., Borroni, R. G., & Costanzo, A. (2020) · Dermatologic Therapy · doi:10.1111/dth.13403 · Cited by 36
Wang, X., Zhao, J., & Qin, L. (2017) · Europe PMC (PubMed Central) · Cited by 34
Metadata
- Authors
- O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A.
- Affiliations
- Yale University (US)
- Cedars-Sinai Medical Center (US)
- Institute of Medical Science, The University of Tokyo (JP)
- Children's Hospital of Pittsburgh (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A
- Venue
- Nature Immunology
- Published
- 2009-05-17
- Volume
- 10
- Issue
- 6
- Pages
- 603-609
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC2709990
- OpenAlex
- W2069571875
- Cited by
- 756
- References
- 36
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 27 · 2023: 26 · 2022: 28 · 2021: 38 · 2020: 32 · 2019: 42 · 2018: 37 · 2017: 36 · 2016: 33 · 2015: 48 · 2014: 61 · 2013: 63 · 2012: 80
- FWCI
- 37.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute on Aging (R00AG029726)
- National Heart, Lung, and Blood Institute (R37HL079142)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17 receptor, colitis, inflammatory bowel disease, IL-23, Th1 polarization, Th1 cytokines, wasting disease, protective immunity
- MeSH terms
- T-bet Transcription Factor, Animals, Cell Differentiation, Cells, Cultured, Colitis, Disease Models, Animal, Interferon-gamma, Lymphocyte Activation, Mice, Inbred BALB C, Leukocyte Common Antigens, Mice, Knockout, Th1 Cells, Adoptive Transfer, Wasting Syndrome, Interleukin-17, T-Box Domain Proteins, Gene Expression Profiling, Cell Proliferation, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review